BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Prefer our daily deals delivered to your inbox? Subscribe to our email here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results